Caribou Biosciences Inc (NASDAQ:CRBU) has a beta value of 2.55 and has seen 1.48 million shares traded in the last trading session. The company, currently
During the last session, Caribou Biosciences Inc (NASDAQ:CRBU)’s traded shares were 1.63 million, with the beta value of the company hitting 2.54. At the end
In the last trading session, 1.38 million shares of the Caribou Biosciences Inc (NASDAQ:CRBU) were traded, and its beta was 2.54. Most recently the company’s
Caribou Biosciences Inc (NASDAQ:CRBU)’s traded shares stood at 1.42 million during the last session, with the company’s beta value hitting 2.53. At the close of
In the latest trading session,, 0.57 million Caribou Biosciences Inc (NASDAQ:CRBU) shares changed hands as the company’s beta touched 2.51. With the company’s most recent
Caribou Biosciences Inc (NASDAQ:CRBU) has a beta value of 2.49 and has seen 1.48 million shares traded in the last trading session. The company, currently
During the recent session, Caribou Biosciences Inc (NASDAQ:CRBU)’s traded shares were 0.7 million, with the beta value of the company hitting 2.49. At the last
In the last trading session, 3.11 million shares of the Caribou Biosciences Inc (NASDAQ:CRBU) were traded, and its beta was 2.47. Most recently the company’s
Caribou Biosciences Inc (NASDAQ:CRBU)’s traded shares stood at 1.35 million during the last session, with the company’s beta value hitting 2.48. At the close of
Caribou Biosciences Inc (NASDAQ:CRBU)’s traded shares stood at 1.0 million during the last session, with the company’s beta value hitting 2.52. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
